Virtual Medicinal Product (VMP) - Dornase alfa 2.5mg/2.5ml nebuliser liquid ampoules

Navigation

Name Details

Name Start Date End Date
Name Current Name Dornase alfa 2.5mg/2.5ml nebuliser liquid ampoules Start Date 01-02-2010 End Date
Previous Name Previous Name Dornase alfa 1mg/ml nebuliser liquid 2.5ml ampoules Start Date 31-01-2003 End Date 31-01-2010

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
2.5
UDFS UOM
ml
Unit Dose UOM
ampoule

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Inhalation
Form
Nebuliser liquid
Ontology Form/Route
solutionnebuliser.inhalation
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
R05CB13
BNF Start Date End Date
Current BNF 03070000 Start Date 04-04-2022 End Date
Previous BNF 03070000 Start Date 02-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
39710211000001103 26-05-2021
320921007 31-01-2003 25-05-2021

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Dornase alfa Based on Ingredient Substance 1 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
6 ampoule
30 ampoule 49643 Part VIIIA Category C